EKSO Q4 2020 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$29M

Q4 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$2M-39.4% YoY

Gross Profit

$1M60.4% margin

Operating Income

-$3M-133.0% margin

Net Income

-$4M-176.4% margin

EPS (Diluted)

$-0.55

QoQ Revenue Growth

-22.2%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$812,000

Balance Sheet

Total Assets

$21M

Total Liabilities

$16M

Stockholders' Equity

$4M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$4M	-39.4%
Gross Profit	$1M	$2M	-26.6%
Operating Income	-$3M	-$3M	-5.6%
Net Income	-$4M	-$3M	-46.1%

Revenue Segments

EksoHealth

$2M91%

EksoWorks

$203,0009%

Geographic Segments

UNITED STATES

$1M50%

Non-US

$1M50%